HTL14242 HTL0014242,98.42%

产品编号:Bellancom-W062697| CAS NO:1644645-32-8| 分子式:C16H8ClFN4| 分子量:310.71

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-W062697
3500.00 杭州 北京(现货)
Bellancom-W062697
4800.00 杭州 北京(现货)
Bellancom-W062697
11000.00 杭州 北京(现货)
Bellancom-W062697
17000.00 杭州 北京(现货)
Bellancom-W062697
25000.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

HTL14242 HTL0014242

产品介绍 HTL14242 (HTL0014242) 是一种高级、口服活性强的 mGlu5 负变构调制器,其 pKipIC50 值分别为 9.3 和 9.2。HTL14242 可用于帕金森病的研究。
生物活性

HTL14242 (HTL0014242) is an advanced and orally active mGlu5 NAM with a pKi and a pIC50 of 9.3 and 9.2, respectively. HTL14242 can be used for the research of parkinson’s disease.

体外研究

HTL14242 is stable in rat plasma, inactive at the hERG ion-channel, and has a clean profile in vitro assays of cytotoxicity in HepG2 cells, the TC50 is >90 μM.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

HTL14242 (oral administration; 1, 3, or 10 mg/kg; sacrificed 1 h postdose) emonstrates an excellent, dose-dependent occupancy of mGlu5 receptors from an oral dose, with an estimated ED50 of 0.3 mg/kg.
HTL14242 (oral administration; 1 mg/ml) exhibits an oral PK Profile, the t1/2, AUCinf and F% are 6.5 hours, 3946 ng/h/mL and 80%, respectively in dog.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Dog (PK study)
Dosage: 3, 10 and 30 mg/kg
Administration: Oral administration; single dose
Result: Had a good PK characteristics in dogs.
体内研究

HTL14242 (oral administration; 1, 3, or 10 mg/kg; sacrificed 1 h postdose) emonstrates an excellent, dose-dependent occupancy of mGlu5 receptors from an oral dose, with an estimated ED50 of 0.3 mg/kg.
HTL14242 (oral administration; 1 mg/ml) exhibits an oral PK Profile, the t1/2, AUCinf and F% are 6.5 hours, 3946 ng/h/mL and 80%, respectively in dog.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Dog (PK study)
Dosage: 3, 10 and 30 mg/kg
Administration: Oral administration; single dose
Result: Had a good PK characteristics in dogs.
性状Solid
溶解性数据
In Vitro: 

DMSO : 12.5 mg/mL (40.23 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.2184 mL 16.0922 mL 32.1844 mL
5 mM 0.6437 mL 3.2184 mL 6.4369 mL
10 mM 0.3218 mL 1.6092 mL 3.2184 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 1.25 mg/mL (4.02 mM); Clear solution

    此方案可获得 ≥ 1.25 mg/mL (4.02 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 12.5 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在 西域 网站选购。
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服